US approves cheap generic version of breakthrough HIV prevention jab — Live Feedhttps://www.live-feeds.com/feed/us-approves-cheap-generic-version-of-breakthrough-hiv-prevention-jabContinuously updated, source-cited coverage. FDA approves first generic version of lenacapavir HIV prevention injectionhttps://www.live-feeds.com/feed/us-approves-cheap-generic-version-of-breakthrough-hiv-prevention-jabhttps://www.live-feeds.com/feed/us-approves-cheap-generic-version-of-breakthrough-hiv-prevention-jab#u179762Fri, 06 Nov 2026 03:35:13 +0000The U.S. Food and Drug Administration approved a low-cost generic version of lenacapavir, a twice-yearly injectable for HIV prevention. Produced by Indian manufacturer Dr Reddy's Laboratories, the generic drug will be available for $40 per person per year in 120 countries. This approval comes 16 months after the original drug was authorized. The move aims to increase access to the breakthrough prevention method in low-income regions where the original medication remains difficult to obtain.Why it mattersLenacapavir is the only available HIV prevention shot administered just twice a year.